Novonesis
412.2 DKK +5.88%11 investors are following this company
Novonesis is a biochemistry company. The company develops enzymes and various microorganisms for industrial use. The enzymes are a protein used in a number of different industries, mainly in the agricultural and food industries. Novozymes products are used in various foods and clothing and the company holds sales on a global level. Novozymes was founded in 1921 and is headquartered in Bagsværd, Denmark.
Revenue
17.9B
EBIT %
22.21 %
P/E
37.75
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Copenhagen
NSIS B
Daily low / high price
382.7 / 416.9
DKK
Market cap
193.03B DKK
Turnover
609.07M DKK
Volume
1.5M
Financial calendar
Interim report
28.08.2024
Annual report
26.02.2025
General meeting
03.04.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Novo Holdings A/S | 25.5 % | 72.4 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Trading statement Q1 2024
Resolutions from the annual shareholders’ meeting 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools